MLMichael J. Leibowitz

Michael J. Leibowitz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael J. Leibowitz has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Scientific societies advancing STEM workforce diversity: Lessons and Outcomes from the Minorities Affairs Committee of the American Society for Cell Biology

    by Verónica A. Segarra, Sydella Blatch, Michael Boyce, Franklin Carrero-Martinez, Renato J. Aguilera, Michael J. Leibowitz, MariaElena Zavala, Latanya Hammonds-Odie, Ashanti Edwards

    Promoting diversity and inclusiveness in the STEM academic workforce remains a key challenge and national priority. Scientific societies can play a significant role in this process through the creation and implementation of programs to foster STEM academic workforce diversification, and by providing mentoring and skills development training that empower scientists from under-represented minority (URM) backgrounds to succeed in their communities of practice. In this article, we provide examples of challenges met by scientific societies in these areas and present data from the American Society for Cell Biology, highlighting the benefits received by trainees through long-term engagement with its programs. The success of these initiatives illustrates the impact of discipline-specific programming by scientific societies in supporting the development of URM scientists and an increasingly diverse and inclusive academic STEM community.

    • 23 June 2017
      • Vol. 90  (2) , 183-193
    Open Access

    Association of Plasmodium falciparum with Human Endothelial Cells in vitro

    by Christopher Utter, Adelfa E. Serrano, John W. Glod, Michael J. Leibowitz

    Endothelial abnormalities play a critical role in the pathogenesis of malaria caused by the human pathogen, Plasmodium falciparum. In serious infections and especially in cerebral malaria, red blood cells infected with the parasite are sequestered in small venules in various organs, resulting in endothelial activation and vascular occlusion, which are believed to be largely responsible for the morbidity and mortality caused by this infection, especially in children. We demonstrate that after incubation with infected red blood cells (iRBCs), cultured human umbilical vein endothelial cells (HUVECs) contain parasite protein, genomic DNA, and RNA, as well as intracellular vacuoles with apparent parasite-derived material, but not engulfed or adherent iRBCs. The association of this material with the HUVECs is observed over 96 hours after removal of iRBCs. This phenomenon may occur in endothelial cells in vivo by the process of trogocytosis, in which transfer of material between cells depends on direct cell contact. This process may contribute to the endothelial activation and disruption involved in the pathogenesis of cerebral malaria.


  • Translational Regulation of Cloned Genes

    by Michael J. Leibowitz

    The actors controlling translational efficiency of mRNA in yeast were studied to aid in design of more efficient vectors for producing heterologous proteins in yeast. A plasmid was constructed with heterologous gene production driven by the yeast CUPI promoter and the killer virus M segment translation initiation signal. Although capped RNAs were more efficiently translated in vitro than uncapped RNAs of the same sequence, changes in the 5' untranslated leader rendered uncapped RNA as translatable as wild-type capped RNA. This result may make cytoplasmic RNA-based cloning vectors feasible in yeast. Yeast, Recombinant DNA gene expression, Translation, Transcription, Polymerase chain reaction, mRNA Cap.